Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study
2016 ◽
Vol 146
(6)
◽
pp. 239-246
2016 ◽
Vol 124
(02)
◽
pp. 99-104
◽
2009 ◽
Vol 117
(08)
◽
pp. 378-385
◽